13 | 3 | 27 |
下载次数 | 被引频次 | 阅读次数 |
目的:探讨硝苯地平联合硫酸镁对子痫前期患者血压控制及妊娠结局的治疗效果。方法:病例回顾性分析2016年1月至2017年12月于我院妇产科就诊的子痫前期患者60例,均给予硝苯地平和硫酸镁治疗,比较治疗前后的治疗效果、血压水平、蛋白尿情况,观察妊娠结局以及药物不良反应发生情况。结果:治疗总有效率为86.67%。所有患者治疗后3天、7天的收缩压和舒张压、尿蛋白含量均低于治疗前(P<0.05)。观察期内不良反应发生率为26.67%。不良妊娠结局中,剖宫产88.33%,早产11.67%。结论:硝苯地平联合硫酸镁治疗子痫前期患者,可以有效控制血压,减轻蛋白尿,效果良好。
Abstract:Objective: To investigate the therapeutic effect of nifedipine combined with magnesium sulfate on blood pressure control and pregnancy outcome in patients with preeclampsia. Methods: A retrospective analysis of 60 patients with preeclampsia from January 2016 to December 2017 in our department of obstetrics and gynecology was conducted. The patients were treated with nifedipine and magnesium sulfate. The therapeutic effect,blood pressure and proteinuria before and after treatment were compared. Pregnancy outcomes and adverse drug reactions were recorded. Results: The total effective rate of treatment was 86.67%. The systolic and diastolic blood pressures and urine protein level of all patients at 3 d and 7 d post treatment were lowered compared with baseline( P<0.05). The incidence of adverse drug reactions during the study period was 26.67%. In the adverse pregnancy outcome,cesarean section account for 88. 33% and premature delivery for 11. 67% of the cases.Conclusion: Nifedipine combined with magnesium sulfate in the treatment of pre-eclampsia patients can effectively control blood pressure and reduce proteinuria with good efficacy.
[1]Kooiman J,Terstappen F,Lely A T.Low birth weight:intrauterine growth restriction or prematurity?[J].Am JKidney Dis,2018,71(6):909.
[2]Umesawa M,Kobashi G.Epidemiology of hypertensive disorders in pregnancy:prevalence,risk factors,predictors and prognosis[J].Hypertens Res,2017,40(3):213-220.
[3]杨孜,张为远.妊娠期高血压疾病诊治指南(2015)[J].中华妇产科杂志,2015,50(10):206-213.
[4]谢幸,苟文丽.妇产科学(第8版)[M].人民卫生出版社,2013:151-179.
[5]刘力生.中国高血压防治指南(2010年基层版)[J].中华心血管病杂志,2011,3(7):42-93.
[6]Rochapenha L,Caldeiradias M,Tanussantos J E,et al.Myeloperoxidase in hypertensive disorders of pregnancy and its relation with nitric oxide[J].Hypertension,2017,69(6):1173-1180.
[7]Shekhar S,Gupta N,Kirubakaran R,et al.Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy:a systematic review and meta-analysis[J].BJOG,2016,123(1):40-47.
[8]Browne F J.Prevention of pre-eclampsia[J].Lancet,2016,280(7247):147-148.
[9]Gao F,Sun S F,Li Z H,et al.Correlation between expression of LIF/Apelin mRNA in placentatissue of hypertensive patients during pregnancy and perinatal outcome[J].Med J Chin People's Liberation Army,2016,34(6):887-889.
[10]高芳,孙素芬,李志红,等.药物三联法治疗妊娠高血压疗效及对血清LIF及Apelin水平的影响[J].现代中西医结合杂志,2016,25(29):3236-3238.
[11]杨东艳,田颖.杞菊地黄汤治疗妊娠高血压综合征的临床疗效[J].陕西中医,2016,37(4):387-389.
[12]党玮,葛春蕾,李冰,等.硝苯地平与硫酸镁治疗妊娠高血压综合征的临床疗效及对患者血清肌酐、HSP70及尿微量白蛋白水平的影响[J].现代生物医学进展,2016,16(32):6357-6359.
[13]Veerbeek J H,Hermes W,Breimer A Y,et al.Cardiovascular disease risk factors after early-onset preeclampsia,late-onset preeclampsia,and pregnancyinduced hypertension[J].Hypertension,2015,65(3):600-606.
[14]顾培君.硝苯地平联合硫酸镁对妊娠期高血压疾病母婴的影响研究[J].安徽医药,2016,20(12):2347-2350.
[15]侯磊,李光辉,邹丽颖,等.全国剖宫产率及剖宫产指征构成比调查的多中心研究[J].中华妇产科杂志,2014,49(10):728-735.
[16]李娜,刘丽红.早产儿临床流行病学研究现状[J].国际儿科学杂志,2016,43(7):576-580.
[17]黄剑磊,贺晓,吴静,等.硝苯地平联合硫酸镁对高龄孕妇妊娠高血压的临床疗效及机制研究[J].现代生物医学进展,2016,16(29):5670-5672.
[18]赵清.硫酸镁与硝苯地平联合对中重度妊娠期高血压疾病患者的有效性评价[J].中国妇幼保健,2016,31(5):1084-1085.
基本信息:
DOI:
中图分类号:R714.244
引用信息:
[1]熊金兰,江碧艳,李克红等.硝苯地平联合硫酸镁对子痫前期患者血压控制及妊娠结局的影响[J].广州医科大学学报,2018,46(06):61-64.
基金信息: